Literature DB >> 15729878

[Thyrotoxic encephalopathy showing reversible diffusion-weighted imaging abnormalities].

Fujio Fujiki1, Yoshio Tsuboi, Nobuhiro Saito, Tatsuo Yamada.   

Abstract

A 31-year-old man was transferred to our emergency room (ER) with acute onset of high-grade fever and consciousness disturbance. His consciousness at ER was severely disturbed with restlessness. No apparent focal neurological signs were seen. MRI with diffusion-weighted images (DWI) showed high signal intensities at the corpus callosum, left cerebellar hemisphere, left deep white matter and right middle cerebellar peduncle. These lesions were low signals in apparent diffusion coefficient(ADC) map, indicating cytotoxic edema. EEG showed enhanced fast waves seen in predominantly frontal regions. CSF examination was normal except elevated initial pressure of 210 mmH2O. He was treated with high dose dexamethasone and acyclovir. His consciousness and high-grade fever with systemic inflammatory responses were dramatically improved after these treatments. Subsequent data showed hyperthyroidism with anti-thyroid stimulating hormone receptor antibodies. This case was thought to be a thyrotoxic encephalopathy with beneficial response to corticosteroid therapy. Abnormalities seen in DWI and EEG were normalized ten days later.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15729878

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  2 in total

1.  Encephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations, follow-up, and outcomes.

Authors:  Gianluca Tamagno; Yahya Celik; Rafael Simó; Marcel Dihné; Kazumi Kimura; Giorgio Gelosa; Byung I Lee; Caroline Hommet; Giovanni Murialdo
Journal:  BMC Neurol       Date:  2010-04-28       Impact factor: 2.474

2.  A thyroid storm patient with protracted disturbance of consciousness and reversible lesion in the splenium of corpus callosum: A case report.

Authors:  Chihiro Namatame; Tomohiro Sonoo; Kazutaka Fukushima; Hiromu Naraba; Hideki Hashimoto; Kensuke Nakamura
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.